v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue    
Net sales $ 74,054 $ 163,692
Cost of sales (48,517) (226,955)
Gross profit (loss) 25,537 (63,263)
Operating Expenses    
Research and development (2,472,117) (2,874,996)
Selling, general and administrative (3,165,168) (1,984,922)
Total operating expenses (5,637,285) (4,859,918)
Loss From Operations (5,611,748) (4,923,181)
Other Income (Expense)    
Interest income 63,678 58,822
Foreign exchange transaction loss (3,221) (1,477)
Interest expense (6,276) (302,048)
Total other income (expense) 54,181 (244,703)
Net Loss (5,557,567) (5,167,884)
Other Comprehensive Loss    
Unrealized loss from investment (5,633) (1,008)
Foreign currency translation loss (888) (305)
Total other comprehensive loss (6,521) (1,313)
Comprehensive Loss $ (5,564,088) $ (5,169,197)
Net Loss Per Common Share – Basic and Diluted (in Dollars per share) $ (0.21) $ (0.22)
Weighted Average Common Shares Outstanding – Basic and Diluted (in Shares) 26,059,625 23,074,049